Head-to-head · Cost-Efficiency Index
Care Bare Rx vs bmiMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Care Bare Rx
People consolidating several telehealth needs on one verified platform who are willing to commit to a 12-month plan to get the cheapest per-month rate.
Visit Care Bare RxbmiMD
Price-driven shoppers who want both molecules cheap and nationwide, with a real month-to-month option if they don't want to prepay a year.
Visit bmiMDThe verdict
bmiMD takes it, leading the Cost-Efficiency Index 82 to 80. Low $129/$179 month-to-month pricing on both molecules nationwide — the $99/$139 headline requires a full 12-month prepay, but a genuine no-commitment option still undercuts most of the ranking. Care Bare Rx still earns a B− — People consolidating several telehealth needs on one verified platform who are willing to commit to a 12-month plan to get the cheapest per-month rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs bmiMD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Care Bare Rx | bmiMD |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 82/100 |
| Semaglutide / mo | $199/mo month-to-month ($185/mo only on a 12-month prepay; the 3-month tier is dearer at $249/mo) | $129/mo (true month-to-month; $99/mo requires 12-mo prepay) |
| Tirzepatide / mo | $299/mo month-to-month ($293/mo only on a 12-month prepay; the 3-month tier is dearer at $356/mo) | $179/mo (true month-to-month; $139/mo requires 12-mo prepay) |
| Semaglutide / yr (modeled) | $2,388 | $1,548 |
| Tirzepatide / yr (modeled) | $3,588 | $2,148 |
| Coverage | All 50 states + Puerto Rico | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #23 | #24 |
Care Bare Rx
80/100Where the value is
- LegitScript-certified and HIPAA-compliant, with both oral (Rybelsus, oral tirzepatide) and injectable options
- Real brand-name Ozempic available (from ~$705/mo) for anyone who specifically wants the on-label pen
- Coverage across all 50 states plus Puerto Rico — wider than most compounded telehealth options
The tradeoffs
- The 3-month plan is a real pricing trap — it costs more per month ($249 semaglutide / $356 tirzepatide) than either month-to-month or the 6-month plan
- The cheapest per-month rate requires a 12-month prepay commitment ($2,218 semaglutide / $3,518 tirzepatide total)
bmiMD
82/100Where the value is
- Low prices on both molecules even month-to-month — $129 semaglutide / $179 tirzepatide, with no dose-based escalation
- A genuine no-commitment month-to-month option exists alongside the cheaper prepay tiers, unlike sites that gate pricing entirely behind a term
- Nationwide all-50 access with both molecules disclosed
The tradeoffs
- The advertised $99/$139 headline requires a full 12-month prepay ($1,188/$1,668 paid upfront) — the true month-to-month rate is 29-30% higher
- Compounded only — no oral or brand option
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.